Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Trichome Pharma is a Spanish pharmaceutical company specialized in the research, development, and commercialization of medical cannabis and cannabinoid-based medicines. Headquartered in Madrid, the company holds necessary authorizations from the Spanish Agency of Medicines and Medical Products (AEMPS) to operate within the strictly regulated medical cannabis framework. Their business model focuses on providing high-quality, standardized cannabinoid products to address unmet needs in chronic pain, oncology, and neurology. Trichome Pharma bridges the gap between agricultural production and pharmaceutical standards, ensuring patient safety and therapeutic consistency. The company actively collaborates with medical professionals and research institutions to advance the clinical understanding of cannabinoid therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Trichome Pharma.